Search Results
An update on the state-of-affairs of BiTEs in the world of AML
An update on AMG 330: can BiTEs be as successful in AML as ALL?
BiTES for the treatment of acute myeloid leukemia (AML) - results with AMG 330 in ex vivo study
Antibodies for AML: updates from ASH
Exciting immunotherapy clinical trials for the management of AML
Why could IMGN632 be an important treatment option for AML?
Phase I study of AMG-330: a BiTe for R/R AML patients
Findings For the BiTE Antibody AMG 330 in Relapsed/Refractory AML
The challenges of choosing the right target antigen in AML compared to ALL
Update on AMG 330 bispecific for R/R AML
Is AML a disease susceptible to novel immunotherapies, such as CAR-T, DARTs, and BITEs?
AMG 673: novel half-life extended anti-CD33/CD3 BiTE in R/R AML
